BHV-1600

N/A

Report date: 2026/04/27 13:31:48

Base Information

Drug NameBHV-1600
Drug Alias NameBHV-1600
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Lysosome-Targeting Chimaeras (LYTAC)
Mechanisms of ActionBeta-1 adrenergic receptor degraders
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsPeripartum CardiomyopathyCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiohaven Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiohaven Ltd
Inactive CompaniesN/A
Active IndicationsPeripartum CardiomyopathyCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A